Trial Profile

A Pilot, Open-Label, Randomized, Crossover, Pharmacokinetic Study Of Enhanced Bioavailability Formulations Of Celecoxib In Healthy Volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 04 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Celecoxib (Primary)
Indications Acute pain; Ankylosing spondylitis; Back pain; Breast cancer; Cervicobrachial syndrome; Dental pain; Dysmenorrhoea; Familial adenomatous polyposis; Gouty arthritis; Juvenile rheumatoid arthritis; Musculoskeletal pain; Non-small cell lung cancer; Osteoarthritis; Pain; Periarthritis; Postoperative pain; Rheumatic disorders; Rheumatoid arthritis; Small cell lung cancer; Stomatitis; Tendinitis; Tenosynovitis
Focus Pharmacokinetics
Sponsors Pfizer

12 Mar 2009 Actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
12 Mar 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
23 Feb 2009 Planned initiation date changed from 1 Jan 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com